1. Home
  2. SBI vs PEPG Comparison

SBI vs PEPG Comparison

Compare SBI & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western Asset Intermediate Muni Fund Inc

SBI

Western Asset Intermediate Muni Fund Inc

HOLD

Current Price

$7.67

Market Cap

111.7M

Sector

Finance

ML Signal

HOLD

Logo PepGen Inc.

PEPG

PepGen Inc.

HOLD

Current Price

$1.59

Market Cap

113.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SBI
PEPG
Founded
1992
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
111.7M
113.3M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
SBI
PEPG
Price
$7.67
$1.59
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$11.17
AVG Volume (30 Days)
46.7K
2.5M
Earning Date
01-01-0001
05-14-2026
Dividend Yield
4.52%
N/A
EPS Growth
N/A
25.61
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.40
$1.01
52 Week High
$8.01
$7.80

Technical Indicators

Market Signals
Indicator
SBI
PEPG
Relative Strength Index (RSI) 39.83 24.17
Support Level $7.67 $1.57
Resistance Level $7.70 $5.37
Average True Range (ATR) 0.07 0.11
MACD -0.01 0.12
Stochastic Oscillator 7.69 20.37

Price Performance

Historical Comparison
SBI
PEPG

About SBI Western Asset Intermediate Muni Fund Inc

Western Asset Intermediate Muni Fd Inc is a diversified closed-end management investment company. The fund's objective is to provide a high level of current income exempt from Federal income taxes. Under normal market conditions, the Fund will invest at least 80% of its total assets in municipal obligations. In addition, under normal market conditions, the Fund will invest at least 80% of its total assets in debt securities that are, at the time of investment, rated investment grade by a nationally recognized statistical rating organization or, if unrated, of equivalent quality as determined by the investment manager.

About PEPG PepGen Inc.

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed that their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle, and the central nervous system. Its pipeline products are: PGN-EDO51, PGN-EDODM1, and others.

Share on Social Networks: